Browse All
Displaying 1 - 5 of 6
Author:Bove, Riley Pietrasanta, Carlo Oreja-Guevara, Celia Hellwig, Kerstin Dobson, Ruth Vukusic, Sandra Lin, Chien-Ju Goncalves Pereira Alvarez, Daniela Zecevic, Dusanka Ferreira, Germano Craveiro, Licinio Pasquarelli, Noemi McElrath, Thomas
Session Name:S7: Multiple Sclerosis: Special Populations and Non-MS CNS Neuroinflammatory Diseases
Topic:Multiple Sclerosis
Program Number:S7.004
Author Institution:University of California, San Francisco, Berkeley, CA University of Milan, Milan, Italy Neurology, Hospital Clínico San Carlos, Madrid, Spain St. Josef Hospital Bochum, Bochum, Germany Wolfson Institute of Population Health, Queen Mary University, London, United Kingdom Hopital Neurologique Pierre Wertheimer, BRON Cedex, France Roche Products Ltd. , Welwyn Garden City, United Kingdom F. Hoffmann-La Roche Ltd., Basel, Switzerland Brigham and Women's Hospital, Boston, MA
Author:Hauser, Stephen Kappos, Ludwig Filippi, Massimo Wolinsky, Jerry Weber, Martin Nicholas, Jacqueline Chognot, Cathy Schneble, Hans-Martin Wang, Qing Giovannoni, Gavin Montalban, Xavier
Session Name:S31: Multiple Sclerosis: Therapeutics and Clinical Decision Making
Program Number:S31.005
Author Institution:UCSF Weill Institute for Neurosciences, San Francisco, CA University Hospital Basel, University of Basel, Research Center for Clinical Neuroimmunology and Neuroscience, Basel, Switzerland Ospedale San Raffaele, Neuroimaging Research Unit, Milan, Italy McGovern Medical School, UTHealth, Houston, TX Institute of Neuropathology and Department of Neurology, Göttingen, Germany OhioHealth Riverside Methodist Hospital, Columbus, OH F. Hoffmann-La Roche Ltd., Basel, Switzerland Queen Mary University, London, United Kingdom Vall d’Hebron University Hospital, Barcelona, Spain
Author:Newsome, Scott Krzystanek, Ewa Selmaj, Krzysztof Goldstick, Lawrence Figueiredo, Catarina Townsend, Ben Wolf, Christian Zecevic, Dusanka Giacobino, Caroline Bortolami, Oscar Shen, Yun-An Kletzl, Heidemarie Clinch, Susanne Centonze, Diego
Program Number:S31.006
Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD School of Health Sciences in Katowice, Katowice, Poland Centrum Neurologii, Lodz, Poland University of Cincinnati, Cincinnati, OH F. Hoffmann-La Roche Ltd., Basel, Switzerland Lycalis sprl, Brussels, Belgium Genentech, San Fransisco, CA Tor Vergata University, Rome, Italy
Author:Hartung, Hans-Peter Holmoy, Trygve Wuerfel, Jens Heer, Yanic Braune, Stefan Bergmann, Arnfin Zuercher, Mel Guye, Sabrina Kuenzel, Thomas Moore, Suzanne Vollmer, Timothy
Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2
Program Number:P9.005
Author Institution:Department of Neurology, UKD, Centre of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University, Dusseldorf, Germany Akershus University Hospital, Nordbyhagen, Norway Roche PDMA Neuroscience, Basel, Switzerland PricewaterhouseCoopers AG, Zurich, Switzerland NeuroTransData, Neuburg an der Donau, Germany F. Hoffmann-La Roche Ltd., Basel, Switzerland University of Colorado, Aurora, CO
Author:Newsome, Scott Goldstick, Lawrence Townsend, Ben Zecevic, Dusanka Augustin, Aisha Figueiredo, Catarina Clinch, Susanne Giacobino, Caroline Bortolami, Oscar Shen, Yun-An Kletzl, Heidemarie Bermel, Robert
Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3
Program Number:P10.003
Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD University of Cincinnati, Cincinnati, OH F. Hoffmann-La Roche Ltd., Basel, Switzerland Roche Products Ltd. , Welwyn, United Kingdom Genentech, San Fransisco, CA Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH
